IMS Oncology

The economics of pharmaceutical oncology have never been better. Innovative new treatments are delivering on the promise of improved outcomes for millions of patients with cancer and the oncology pipeline is the richest in number of all therapeutic categories. But the current environment for the business of cancer is beginning to threaten its future. The competition is intensifying and payers are starting to react.

Find out why manufacturers may soon have to fight it out for a share of a relatively finite pie in “Staying ahead in the oncology market’s golden age” - the latest thinking from IMS experts.

Please complete the following form to download this comprehensive white paper on oncology.

* Required fields.

* Title
Mr
Mrs
Ms
Dr
Other
* First Name
* Last Name
* Job Title
* Email Address
Telephone Number
* Company
Street
Town
Postal/Zip Code
* Country
Comments
 
We (IMS Health HQ Limited) hold your details on our database so that we may keep you informed about company products and services which may be of interest to you. Your information may be shared for this purpose within the IMS group of companies including in the US. If you do not wish to receive further information from the IMS group, please contact (IMS Service Centre, 7 Harewood Avenue, London NW1 6JB) or email optout@imshealth.com.